A loss of TLR4 or a mutated allele, such as those found in some breast cancer patients, diminishes the interaction between OXP and HMGB1; relapse after chemotherapy in these patients is more common than in those with a normal TLR4 allele [287,290,292,293]. Here, TLR4 is linked to breast carcinoma.